Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nada B Lawand, Nayef E Saadé, Omar M El-Agnaf & Bared Safieh-Garabedian. (2015) Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease. Expert Opinion on Therapeutic Targets 19:10, pages 1351-1360.
Read now
Read now
Jeremy J Kudrna & Kenneth E Ugen. (2015) Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations. Human Vaccines & Immunotherapeutics 11:8, pages 1921-1926.
Read now
Read now
Articles from other publishers (29)
Yi Zhuo, Xuan Li, Zhengwen He & Ming Lu. (2023) Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease. Stem Cell Research & Therapy 14:1.
Crossref
Crossref
Ankita Singh & Tiratha Raj Singh. (2023) Innate and adaptive glial cell responses in Alzheimer’s disease. Exploration of Neuroprotective Therapy, pages 90-104.
Crossref
Crossref
Nan Zhang, Mengru Li, Ziye Hou, Lan Ma, Ayesha Younas, Ziyi Wang, Xinchi Jiang & Jianqing Gao. (2022) From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment. Journal of Controlled Release 350, pages 107-121.
Crossref
Crossref
Asim Hussain, Hamza Rafeeq, Nimra Munir, Zara Jabeen, Nadia Afsheen, Khalil ur Rehman, Muhammad Bilal & Hafiz M. N. Iqbal. (2021) Dendritic Cell–Targeted Therapies to Treat Neurological Disorders. Molecular Neurobiology 59:1, pages 603-619.
Crossref
Crossref
Pingping Wang, Lifen Yao, Meng Luo, Wenyang Zhou, Xiyun Jin, Zhaochun Xu, Shi Yan, Yiqun Li, Chang Xu, Rui Cheng, Yan Huang, Xiaoyu Lin, Kexin Ma, Huimin Cao, Hongxin Liu, Guangfu Xue, Fang Han, Huan Nie & Qinghua Jiang. (2021) Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson’s disease. Cell Discovery 7:1.
Crossref
Crossref
Mohammadmahdi Sabahi, Asef Joshaghanian, Mahsa Dolatshahi, Parnian Jabbari, Farzaneh Rahmani & Nima Rezaei. (2021) Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases. Journal of Molecular Neuroscience 71:7, pages 1410-1424.
Crossref
Crossref
Vinata Vedam-Mai. (2021) Harnessing the immune system for the treatment of Parkinson’s disease. Brain Research 1758, pages 147308.
Crossref
Crossref
Sonia George, Trevor Tyson, Nolwen L. Rey, Rachael Sheridan, Wouter Peelaerts, Katelyn Becker, Emily Schulz, Lindsay Meyerdirk, Amanda R. Burmeister, Christian U. von Linstow, Jennifer A. Steiner, Martha L. Escobar Galvis, Jiyan Ma, J. Andrew Pospisilik, Viviane Labrie, Lena Brundin & Patrik Brundin. (2021) T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils. Journal of Parkinson's Disease 11:2, pages 585-603.
Crossref
Crossref
Sara Konstantin Nissen, Sara Almeida Ferreira, Ida Hyllen Klæstrup & Marina Romero-Ramos. 2021. Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson's Disease. Mechanisms of Cell Death and Approaches to Neuroprotection/Disease Modification in Parkinson's Disease
261
301
.
Bhumika Kumar, Mukesh Pandey, Faheem H. Pottoo, Faizana Fayaz, Anjali Sharma & P.K. Sahoo. (2020) Liposomes: Novel Drug Delivery Approach for Targeting Parkinson’s Disease. Current Pharmaceutical Design 26:37, pages 4721-4737.
Crossref
Crossref
Stefan Bartl, Abid Oueslati, Amber L. Southwell, Alberto Siddu, Michela Parth, Linda Suzanne David, Alexander Maxan, Nina Salhat, Markus Burkert, Andreas Mairhofer, Theresa Friedrich, Halyna Pankevych, Katja Balazs, Guenther Staffler, Michael R. Hayden, Francesca Cicchetti & Oskar W. Smrzka. (2020) Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease. Neurobiology of Disease 141, pages 104943.
Crossref
Crossref
Öznur Özge Özcan, Mesut Karahan, Palanirajan Vijayaraj Kumar, Shen Leng Tan & Yi Na Tee. 2020. Current and Future Aspects of Nanomedicine. Current and Future Aspects of Nanomedicine.
Katherine E. Olson, R. Lee Mosley & Howard E. Gendelman. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
335
370
.
R. Lee Mosley, Yaman Lu, Katherine E. Olson, Jatin Machhi, Wenhui Yan, Krista L. Namminga, Jenell R. Smith, Scott J. Shandler & Howard E. Gendelman. (2019) A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
Sara A. Ferreira & Marina Romero-Ramos. (2018) Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Javier Villadiego, Adahir Labrador-Garrido, Jaime M. Franco, Magdalena Leal-Lasarte, Erwin J. De Genst, Christopher M. Dobson, David Pozo, Juan J. Toledo-Aral & Cintia Roodveldt. (2018) Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model. Glia 66:1, pages 191-205.
Crossref
Crossref
Anne K. Braczynski, Jörg B. Schulz & Jan-Philipp Bach. (2017) Vaccination strategies in tauopathies and synucleinopathies. Journal of Neurochemistry 143:5, pages 467-488.
Crossref
Crossref
Itzia Jimenez-Ferrer, Michael Jewett, Ashmita Tontanahal, Marina Romero-Ramos & Maria Swanberg. (2017) Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Neurobiology of Disease 106, pages 279-290.
Crossref
Crossref
M. von Euler Chelpin & T. Vorup-Jensen. (2017) Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments. Scandinavian Journal of Immunology 85:5, pages 321-330.
Crossref
Crossref
Marion Delenclos, Simon Moussaud & Pamela J. McLean. 2017. Disease-Modifying Targets in Neurodegenerative Disorders. Disease-Modifying Targets in Neurodegenerative Disorders
175
198
.
Josefine R. Christiansen, Mads N. Olesen, Daniel E. Otzen, Marina Romero-Ramos & Vanesa Sanchez-Guajardo. (2016) α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology. Journal of Neuroinflammation 13:1.
Crossref
Crossref
Katherine E. Olson, Aditya N. Bade, Charles R. Schutt, Jingdong Dong, Scott J. Shandler, Michael D. Boska, R. Lee Mosley, Howard E. Gendelman & Yutong Liu. (2016) Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson’s Disease. Neurotherapeutics 13:3, pages 635-646.
Crossref
Crossref
Sandeep Vasant More & Dong-Kug Choi. (2016) Emerging preclinical pharmacological targets for Parkinson's disease. Oncotarget 7:20, pages 29835-29863.
Crossref
Crossref
Hongwei Qin, Jessica A. Buckley, Xinru Li, Yudong Liu, Thomas H. FoxIIIIII, Gordon P. Meares, Hao Yu, Zhaoqi Yan, Ashley S. Harms, Yufeng Li, David G. Standaert & Etty N. Benveniste. (2016) Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. The Journal of Neuroscience 36:18, pages 5144-5159.
Crossref
Crossref
Peter Ludewig, Mattia Gallizioli, Xabier Urra, Sarah Behr, Vanessa H. Brait, Mathias Gelderblom, Tim Magnus & Anna M. Planas. (2016) Dendritic cells in brain diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 352-367.
Crossref
Crossref
K. E. Olson, L. M. Kosloski-Bilek, K. M. Anderson, B. J. Diggs, B. E. Clark, J. M. Gledhill, S. J. Shandler, R. L. Mosley & H. E. Gendelman. (2015) Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice. Journal of Neuroscience 35:50, pages 16463-16478.
Crossref
Crossref
Hugo González, Francisco Contreras & Rodrigo Pacheco. (2015) Regulation of the Neurodegenerative Process Associated to Parkinson’s Disease by CD4+ T-cells. Journal of Neuroimmune Pharmacology 10:4, pages 561-575.
Crossref
Crossref
Sonia George & Patrik Brundin. (2015) Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation. Journal of Parkinson's Disease 5:3, pages 413-424.
Crossref
Crossref
V. Sanchez-Guajardo, N. Tentillier & M. Romero-Ramos. (2015) The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments. Neuroscience 302, pages 47-58.
Crossref
Crossref